Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
21 February, 2018 05:19 IST
Dr Reddy's to get up to USD 32.5 mn milestone payments for DFD-06
Source: IRIS | 22 Aug, 2017, 10.33AM
Comments  |  Post Comment
 

Dr. Reddy's Laboratories, through its wholly owned subsidiary Promius Pharma, LLC, announced today that it has out-licensed the future development, manufacturing, and commercialization rights of DFD-06, a topical high potency steroid, to Encore Dermatology Inc. The drug is intended to be used for treatment of moderate to severe plaque psoriasis.

Under the terms of the agreement, Encore will be responsible for the commercialization of DFD-06 in the United States. Promius Pharma is eligible to receive certain pre- and post-commercialization milestone payments of up to USD 32.5 million, followed by fixed royalty payments on net sales.

'We believe Encore and its management team are well positioned to realize the full potential of this asset DFD-06. We look forward to obtaining NDA approval this fall, enabling Encore's management team to quickly deliver this product to the providers and their patients." says Anil Namboodiripad, Ph.D., Senior Vice President, Proprietary Products, and President, Promius Pharma.

Shares of the company gained Rs 21.85, or 1.13%, to trade at Rs 1,955.00. The total volume of shares traded was 15,230 at the BSE (10.22 a.m., Tuesday).

   

Dr Reddy`S Laboratories Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
CMI Energy bags order from Engineers India - 20-Feb-2018 14:27
Suven Life Sciences secures product patents in India and South Korea - 20-Feb-2018 10:47
IndusInd Bank intimates of no direct credit exposure to Nirav Modi - 20-Feb-2018 09:58
JSW Energy enters into MoU with Govt of Maharashtra - 20-Feb-2018 09:53
Subex partners with Pod Solution - 20-Feb-2018 09:49
Glenmark Pharma presents findings from Phase 2a study of GBR 830 - 19-Feb-2018 10:10
L&T Construction secures order worth Rs 16.80 bn - 19-Feb-2018 09:52
BHEL commissions 18 MW hydro-electric project in Punjab - 16-Feb-2018 13:33
Reliance Communication update on asset monetization - 16-Feb-2018 12:06
8K Miles Software launches blockchain platform 8K Health Edge - 16-Feb-2018 10:16
Mahindra Group to invest Rs 1.76 bn in Zoomcar - 16-Feb-2018 10:06
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer